A temporary regulation to manage an impending shortage due to extraordinary prescribing patterns of chloroquines observed during early phase of COVID-19 epidemic

CONCLUSION: After an observed increase in prescriptions of C/HC, a temporary regulation was introduced on 2nd April 2020 to reduce prescriptions from specialists not usually prescribing C/HC to avoid shortages for patients within approved indications. Subsequently, dispensed prescriptions decreased from April and remained at pre-COVID-19 levels thereafter.PMID:38188250 | PMC:PMC10770639 | DOI:10.48101/ujms.v128.10033

Source: Upsala Journal of Medical Sciences - January 8, 2024 Category: General Medicine Authors: Karl-Mikael K älkner Anders Sundstr öm Maria Juhasz Haverinen Kenneth Nordback Veronica Arthurson Bj örn Zethelius Rickard Ljung Source Type: research